Vaccine development for COVID-19

Presenter:

Hanneke Schuitemaker
Global Head of Viral Vaccine Discovery and Translational Medicine
   and the Disease Area Stronghold Leader for Viral Vaccines in Janssen Vaccines and Prevention
Professor in Virology, Amsterdam University Medical Center

Objective:

On January 12, 2020, the publication of the genetic code of SARS-CoV-2, the virus that causes COVID-19, triggers Janssen Vaccines to start the development of a prophylactic COVID-19 vaccine. The seminar will capture Janssen’s vaccine design, preclinical evaluation, production of clinical trial material for phase 1 studies and in parallel the ‘at-risk’ ramp-up of large scale manufacturing at unprecedented speed without cutting on safety. In addition, an overview of the field will be provided.

What is the ISBT webinar series?
The International Society of Blood Transfusion (ISBT) webinars are online lectures on a wide range of transfusion medicine-related topics presented by experts. The webinars are hosted monthly and are accessible for ISBT members. After attending a webinar you can receive a certificate of attendance upon request. 

How can I attend an ISBT webinar?
For each webinar, members of ISBT receive an invitation via email with the registration link. Questions about the webinars can be sent to the ISBT Communications Coordinator: communication@isbtweb.org